zealand_logo_RGB_01.png
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
December 08, 2022 16:00 ET | Zealand Pharma
Company announcement – No. 57 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. December 8, 2022 –...
zealand_logo_RGB_01.png
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
December 02, 2022 12:05 ET | Zealand Pharma
Company announcement – No. 56/ 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
zealand_logo_RGB_01.png
Zealand Pharma grants sign-on warrants and performance stock units under the employee warrant program and management long-term incentive program
December 02, 2022 12:00 ET | Zealand Pharma
Company announcement – No. 55/ 2022 Zealand Pharma grants sign-on warrants and performance stock units under the employee warrant program and management long-term incentive program ...
zealand_logo_RGB_01.png
Total number of shares and voting rights in Zealand Pharma at November 30, 2022
November 30, 2022 11:05 ET | Zealand Pharma
Company announcement – No. 54 / 2022 Total number of shares and voting rights in Zealand Pharma at November 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. November 30, 2022 – Zealand Pharma A/S...
zealand_logo_RGB_01.png
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
November 17, 2022 15:55 ET | Zealand Pharma
Company announcement – No. 53 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. November 17,...
zealand_logo_RGB_01.png
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
November 17, 2022 11:29 ET | Zealand Pharma
Company announcement – No. 52 / 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
zealand_logo_RGB_01.png
Zealand Pharma Announces Financial Results for the First Nine Months of 2022
November 10, 2022 09:00 ET | Zealand Pharma
Company announcement No. 51 / 2022 Zealand Pharma Announces Financial Results for the First Nine Months of 2022 Copenhagen, Denmark November 10, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....
zealand_logo_RGB_01.png
Zealand Pharma to Participate in Upcoming Investor Conferences
November 08, 2022 08:30 ET | Zealand Pharma
Company announcement – No. 50 / 2022 Zealand Pharma to Participate in Upcoming Investor Conferences Copenhagen, Denmark and Boston, MA, U.S. November 8, 2022 – a Zealand Pharma A/S (CVR-no....
zealand_logo_RGB_01.png
Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022
November 03, 2022 04:00 ET | Zealand Pharma
Company announcement – No. 49 / 2022 Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022 Copenhagen, Denmark and Boston, MA,...
zealand_logo_RGB_01.png
Zealand Pharma Announces Presentations at The Obesity Society Annual Meeting
November 01, 2022 12:00 ET | Zealand Pharma
Press release – No. 7 / 2022 Zealand Pharma Announces Presentations at The Obesity Society Annual Meeting Results from the phase 2 clinical trial of GCGR/GLP-1R dual agonist BI 456906 showing...